The pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch® capsules 2.5 μg), a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients

4Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Nakao, K., Ando, A., Hirakata, M., Ando, N., Takeshita, K., Miyamoto, Y., & Mochizuki, H. (2010). The pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch® capsules 2.5 μg), a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.135.205

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free